November 01, 2018 Flipping for the win at Strongbridge Biopharma Strongbridge's deal with Novo Nordisk over Macrilen tops up the former's cash pile and pays off debt just 10 months after the company licensed the project from Aeterna Zentaris.
August 09, 2018 Strongbridge steps on the gas with Cushing's project Strongbridge will seek accelerated approval for Recorlev after encouraging data, but speed is not the most important factor for success.
June 01, 2018 Upcoming events – Rare disease data for Sangamo and Strongbridge Results of a phase I/II trial in Hunter syndrome will have implications for Gliead, and a Cushing's candidate will be watched for side-effects.